Author | Steven A. Fischkoff, MD | OncLive

Author | Steven A. Fischkoff, MD

Articles

Dr. Fischkoff on Vision for TIL Therapy in Melanoma

August 03, 2016

Video

Steven A. Fischkoff, MD, chief medical officer of Lion Biotechnologies, Inc, discusses his vision for tumor-infiltrating lymphocyte therapy for patients with melanoma.

x